Overton’s nomination withdrawal means no clear end for FDA leadership vacuum
The Hill reports that the White House abruptly withdrew Heidi Overton as President Trump's nominee to lead the Food and Drug Administration. The outlet says this leaves the agency without stable leadership six months after the former commissioner resigned, which has made industry observers anxious. According to The Hill, the last-minute withdrawal surprised senators this week, including Sen. Bill Cassidy (R-La.), who chairs the Senate Health committee.
Based on The Hill's report - only one outlet has covered this so far. Read the original.Coverage 1 source · 1 report
Chronological.
-
Overton’s nomination withdrawal means no clear end for FDA leadership vacuum
The White House’s abrupt withdrawal of Heidi Overton as President Trump’s nominee to lead the Food and Drug Administration (FDA) means the agency will remain without stable leadership six months after the former commissioner resigned, leaving industry observers anxious. The Trump administration’s last-minute pulling of Overton’s nomination caught senators by surprise this week. Sen. Bill Cassidy (R-La.), chair of the Senate Health,…
Discussion 0 comments